v3.26.1
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (UNAUDITED) - USD ($)
$ in Millions
Total
Preferred Stock
Common Stock
Additional Paid-In Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Treasury Stock
Beginning balance (in shares) at Dec. 31, 2024   4,975,000 702,224,674        
Beginning balance at Dec. 31, 2024 $ 60,784 $ 0 $ 7 $ 36,428 $ 64,505 $ (9,286) $ (30,870)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Comprehensive income (loss) 3,161       1,404 1,757  
Dividends—common stock (in shares) [1]     12,211        
Dividends—common stock [1] (234)     2 (236)    
Dividends—preferred stock (57)       (57)    
Purchases of treasury stock (375)           (375)
Issuances of common stock and restricted stock, net of forfeitures (in shares)     3,572,356        
Issuances of common stock and restricted stock, net of forfeitures 93     93      
Exercises of stock options (in shares)     14,070        
Exercises of stock options 1     1      
Compensation expense for restricted stock units 169     169      
Ending balance (in shares) at Mar. 31, 2025   4,975,000 705,823,311        
Ending balance at Mar. 31, 2025 63,542 $ 0 $ 7 36,693 65,616 (7,529) (31,245)
Beginning balance (in shares) at Dec. 31, 2024   4,975,000 702,224,674        
Beginning balance at Dec. 31, 2024 60,784 $ 0 $ 7 36,428 64,505 (9,286) (30,870)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Comprehensive income (loss) (406)            
Ending balance (in shares) at Jun. 30, 2025   4,980,700 706,729,115        
Ending balance at Jun. 30, 2025 110,956 $ 0 $ 7 63,465 60,892 (6,819) (6,589)
Beginning balance (in shares) at Mar. 31, 2025   4,975,000 705,823,311        
Beginning balance at Mar. 31, 2025 63,542 $ 0 $ 7 36,693 65,616 (7,529) (31,245)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Comprehensive income (loss) (3,567)       (4,277) 710  
Dividends—common stock (in shares) [1]     2,163        
Dividends—common stock [1] (388)       (388)    
Dividends—preferred stock (65)       (65)    
Purchases of treasury stock (167)           (167)
Issuances of common stock and restricted stock, net of forfeitures (in shares)     903,641        
Issuances of common stock and restricted stock, net of forfeitures 111     111      
Compensation expense for restricted stock units 214     214      
Reissuance of treasury stock related to the Transaction 50,586     25,763     24,823
Issuances of preferred stock related to the Transaction (in shares)   10,700          
Issuances of preferred stock related to the Transaction 1,068     1,068      
Redemptions of preferred stock (shares)   (5,000)          
Redemptions of preferred stock (500)     (506) 6    
Fair value of purchase consideration related to restricted stock units 122     122      
Ending balance (in shares) at Jun. 30, 2025   4,980,700 706,729,115        
Ending balance at Jun. 30, 2025 110,956 $ 0 $ 7 63,465 60,892 (6,819) (6,589)
Beginning balance (in shares) at Dec. 31, 2025   4,980,700 708,546,381        
Beginning balance at Dec. 31, 2025 113,616 $ 0 $ 7 64,031 65,192 (5,468) (10,146)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Comprehensive income (loss) 1,763       2,174 (411)  
Dividends—common stock (in shares) [1]     16,317        
Dividends—common stock [1] (502)     3 (505)    
Dividends—preferred stock (73)       (73)    
Purchases of treasury stock (2,793)           (2,793)
Issuances of common stock and restricted stock, net of forfeitures (in shares)     4,117,161        
Issuances of common stock and restricted stock, net of forfeitures 119     119      
Exercises of stock options (in shares)     15,553        
Exercises of stock options 1     1      
Compensation expense for restricted stock units 130     130      
Ending balance (in shares) at Mar. 31, 2026   4,980,700 712,695,412        
Ending balance at Mar. 31, 2026 112,261 $ 0 $ 7 64,284 66,788 (5,879) (12,939)
Beginning balance (in shares) at Dec. 31, 2025   4,980,700 708,546,381        
Beginning balance at Dec. 31, 2025 113,616 $ 0 $ 7 64,031 65,192 (5,468) (10,146)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Comprehensive income (loss) 4,362            
Reissuance of treasury stock related to the Transaction 1,878     461     1,417
Fair value of purchase consideration related to restricted stock units 13     13      
Ending balance (in shares) at Jun. 30, 2026   4,980,700 714,105,102        
Ending balance at Jun. 30, 2026 113,793 $ 0 $ 7 65,105 69,250 (6,300) (14,269)
Beginning balance (in shares) at Mar. 31, 2026   4,980,700 712,695,412        
Beginning balance at Mar. 31, 2026 112,261 $ 0 $ 7 64,284 66,788 (5,879) (12,939)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Comprehensive income (loss) 2,599       3,020 (421)  
Dividends—common stock (in shares) [1]     4,141        
Dividends—common stock [1] (500)     1 (501)    
Dividends—preferred stock (57)       (57)    
Purchases of treasury stock (2,747)           (2,747)
Issuances of common stock and restricted stock, net of forfeitures (in shares)     1,405,549        
Issuances of common stock and restricted stock, net of forfeitures 139     139      
Compensation expense for restricted stock units 207     207      
Ending balance (in shares) at Jun. 30, 2026   4,980,700 714,105,102        
Ending balance at Jun. 30, 2026 $ 113,793 $ 0 $ 7 $ 65,105 $ 69,250 $ (6,300) $ (14,269)
[1] We declared dividends per share on our common stock of $0.80 and $0.60 in the second quarter of 2026 and 2025, respectively, and $1.60 and $1.20 in the first six months of 2026 and 2025, respectively